drugset / Trial / NCT04814537

Optimal Bupivacaine Dose for Initiation of Labor Epidural Techniques

NCT04814537 ↗

Phase 4 Completed 100 enrolled Brigham and Women's Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.

Timeline

Start
2021-02-25
Primary completion
2022-03-23
Completion
2022-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 20 mg Other
Subject Bupivacaine Other / unclassified 22.5 mg Other
Subject Bupivacaine Other / unclassified 25 mg Other
Subject Bupivacaine Other / unclassified 27.5 mg Other
Subject Bupivacaine Other / unclassified 30 mg Other
Subject Bupivacaine Other / unclassified 32.5 mg Other
Subject Bupivacaine Other / unclassified 35 mg Other
Subject Bupivacaine Other / unclassified 37.5 mg Other
Subject Bupivacaine Other / unclassified 40 mg Other

Indications

No indication recorded.